Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-02-11

FDA Approved: ALLOPURINOL — Supplemental Application (Accord Healthcare Inc.)

View source ↗

Summary

FDA approved a supplemental application for Allopurinol from Accord Healthcare Inc., indicating an additional approval for the generic product under the ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Allopurinol (Allopurinol)

Snippet

SUPPL AP for ALLOPURINOL (ALLOPURINOL)